Showing results (71-80 of 80) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099M Al-Sarraf, M LeBlanc, P G Giri, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Sequences of taxol and cisplatin: a phase I and pharmacologic studyE K Rowinsky, M R Gilbert, W P McGuire, et al.Nuclear Medicine Communications|December 1, 1985
The use of a vasoconstrictor to improve tumour blood flow in intra-arterial chemotherapy: preliminary reportH A Ziessman, A A Forastiere, R H Wheeler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitorE K Rowinsky, L B Grochow, C B Hendricks, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neckA S Garden, J Harris, E E Vokes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependenceE K Rowinsky, S H Kaufmann, S D Baker, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2014
Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303)H J Wanebo, J Lee, B A Burtness, et al.Cancer Chemotherapy and Pharmacology|February 3, 2011
Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology GroupH H Yoon, P Catalano, M K Gibson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagusE I Heath, B A Burtness, R F Heitmiller, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2014
A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinomaC H Chung, J W Lee, R J Slebos, et al.Pageof 8